PharmaCyte Biotech, Inc. (PMCB)

PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes. The company was founded on October 28, 1996 and is headquartered in Las Vegas, NV.

Address

23046 AVENIDA DE LA CARLOTA, SUITE 600
LAGUNA HILLS, CA 92653

Founded

1996

Number of Employees

2

Website

http://pharmacyte.com

Buyback

Buyback Data 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
$ Amount Purchased
($ in 000s )		 - - - - - - - - $7,635 $28,394 - $18,015
Average Price - - - - - - - - $2.66 $3.20 - $3.07
# Shares Purchased - - - - - - - - 2,875,496 8,860,385 - 5,867,941
Buyback Performance 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
Total Return to Date - - - - - - - - -62.3% -68.8% - -67.4%
S&P 500 Return to Date - - - - - - - - 37.3% 31.3% - 34.3%
Excess Total Return - - - - - - - - -99.6% -100.1% - -101.7%
Quartile Rank
Percentile Rank - - - - - - - - 8% 3% - 9%
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)

People also followed
AGRITEK HOLDINGS, INC.
Sonnet BioTherapeutics Holdings, Inc.
CohBar, Inc.
WALKER WAYNE REMELL

AYRO, Inc.